Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

Ang et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69d6fc8e5413bc3de5ab328f — DOI: https://doi.org/10.1056/nejmoa0912217

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)· 1995 · 4,814 citations
2. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the radiation therapy oncology group study 81-17· 1990 · 192 citations
3. Toxicity and response criteria of the Eastern Cooperative Oncology Group· 1982 · 11,562 citations
4. Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial· 2008 · 2,780 citations
5. Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications· 2009 · 207 citations